Don't Get Left Behind: New Scientific Findings to Be Presented at CROI 2017
February 9, 2017
Get ready for it. Next week, there will be a flood of new HIV data being released at the annual Conference on Retroviruses and Opportunistic Infections (CROI), and AIDS.gov will be there to bring you the highlights. I'm sure that most of you already know that CROI is one of the most important scientific meetings of the year when it comes to HIV research. This year, the meeting will take place in Seattle from February 13 to February 16.
Results from an incredible number of studies are presented each year at CROI, and it's the place where important new advances are often presented for the first time. The meeting covers a wide range of research about HIV, AIDS, and related infections, including viral hepatitis. The types of studies presented include: basic science; epidemiology; clinical trials evaluating new prevention, care, and treatment strategies; and applied research that translates clinical trial results into improved programs and services. This year, I'm expecting to see important new data about recent trends in HIV incidence, treatment as prevention, new and existing forms of PrEP, HIV-related disparities, and many other topics.
One of the things I appreciate most about CROI is how quickly and completely they make information available to people who are not able to attend the meeting in person. All of the plenary session talks, oral presentations in program sessions, and workshops will be available online within 24 hours after they are presented at the conference website, www.CROIconference.org. In addition, all of the abstracts and posters presented at the meeting will be available at the conference website within a week after the conference is over.
It's important to have access to all of this information, but sometimes it's hard to sort through the large number of presentations to identify the ones that represent the most important advances or have the most significant implications for HIV prevention, care, and treatment in the United States. That's why AIDS.gov is going to be there capturing and sharing some of the highlights via Facebook Live and through blogs that will be published throughout the conference. Our goal is to provide information that supports the well-being of people at risk for, or living with, HIV.
So tune in to AIDS.gov next Tuesday through Thursday (February 14-16) to see daily Facebook Live updates from some of the U.S. Government's leading experts on HIV. Each day, NIH's Dr. Carl Dieffenbach will share information on key findings from the conference, and we will also interview Dr. Jonathan Mermin, Director of the CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. In addition, we'll be taking with other federal leaders who will be presenting research on HIV and youth.
You can view the live streams directly from AIDS.gov's Facebook page. We'll have an interview schedule soon, so check our website for specific times.
We encourage everyone to watch, comment, and share! As always, you don't need a Facebook account to watch the live videos, but you will need one to comment and react to them on Facebook.
Although we don't yet know about all of the research that will be presented at CROI, it is certain that findings presented there next week will affect what we say and do in HIV prevention, care, and treatment. Don't be the last to know! Look to AIDS.gov for highlights of CROI 2017, and make sure to use the CROI website to get full access to all of the science that will be presented.
Richard Wolitski, Ph.D., is director of the Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services.
This article was provided by HIV.gov. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.